Compare Pharmacokinetic(PK) Profiles of XZK vs Lovastatin in Healthy Male Volunteers
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare laboratory tests profiles of a botanic drug
XueZhiKang (XZK) 300 mg capsules versus a marketed drug Lovastatin 20 mg tablets in healthy
male volunteers between 18 and 50 years of age.